The Indian government is expected to approve the Oxford/AstraZeneca vaccine by next week for emergency use according to two sources reported by Reuters. India will be the first country to approve the British drugmaker vaccine as vaccine trails continue to be in process.
India’s Central Drugs Standard Control Organization (CDSCO) first reviewed the three applications on December 9 and requested more data from all the companies, SII, Pfizer, and Bharat Biotech. Serum Institute of India (SII) making AstraZeneca shot vaccine submitted all the details government requested and are likely to get approval by next week. The Indian government is also considering the emergency use of Pfizer Inc and Indian company Bharat Biotech.
The AstraZeneca vaccine is vital for developing nations. It is cheap, can be easily transported and suitable for countries with hot climates. Also, additional sources reported that Indian drugmaker Bharat Biotech is also very close to submitting all the data government requested.
The recent late-stage trials of AstraZeneca in the UK and Brazil released indicated the efficacy of 62% when given two full doses, but efficacy increased to 90% when the half dose was given to the participants. But, Indian regulators are considering only a two-dose regimen of the vaccine for the citizens. The government has not yet signed with any company for the supply of vaccines and is expected to close the deal soon.